Vishnu Mohanan

Affiliations

Genentech, Inc., South San Francisco, California, USA.

Publications (1)

A phase I, randomized, ascending-dose study to assess safety, pharmacokinetics, and activity of GDC-8264, a RIP1 inhibitor, in healthy volunteers.

Clinical and translational science

Avec: Nicholas S Jones , Smita Kshirsagar , Vishnu Mohanan , Vidya Ramakrishnan , Flavia Di Nucci , Ling Ma , Jialin Mao , Hao Ding , Sha Klabunde , Domagoj Vucic , Lin Pan , Annemarie N Lekkerkerker , Yuan Chen , Michael E Rothenberg

Réseau de co-auteurs

Nicholas S Jones 1 collaboration

Smita Kshirsagar 1 collaboration

Vidya Ramakrishnan 1 collaboration

Flavia Di Nucci 1 collaboration

Ling Ma 1 collaboration

Jialin Mao 1 collaboration

Hao Ding 1 collaboration

Sha Klabunde 1 collaboration

Domagoj Vucic 1 collaboration

Lin Pan 1 collaboration

Annemarie N Lekkerkerker 1 collaboration

Yuan Chen 1 collaboration

Michael E Rothenberg 1 collaboration